Not Signed In - Cardesartan Helps Improve Subjective Symptoms in Heart Failure Patients, Large-Scale CHARM Study
Tue, 07 Jun 2005 10:00 AM EST
... Tokyo (JCNN) - Takeda Pharmaceutical (TSE: 4502) announced that the results of the CHARM (Candesartan in Heart Failure - Assessment of Reduction in Mortality and Morbidity) study, a large-scale evaluation study of candesartan cilexetil, were published in the June 2005 issue of scientific magazine The European Journal of Heart Failure... click link for more info. ...
Related Topics
- Congestive Heart Failure
- Kidney Failure
- Heart Disease
- Most people with small tumors will have no permanent paralysis of the face after surgery. However, about two-thirds of patients with large tumors will have some permanent facial weakness after surgery.
- Coronary Heart Disease
- Heart Defects
- Heart Murmur
- Heart Diseases
- Asperger Syndrome
- BNP
- Right-sided heart failure
- Heart and Circulation
- Heart Attack
- Left-sided heart failure
- Congestive heart failure (rare)
- Heart failure or abnormal rhythm
- Angina
- Congenital Heart Disease
- Stroke
- Heart Bypass Surgery
email this page
print this page
bookmark this page
feedback on this page
